Chunsik Lee Selected Research

Co-Repressor Proteins

6/2022

Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunsik Lee Research Topics

Disease

9	Neoplasms (Cancer) 01/2023 - 01/2004
9	Pathologic Neovascularization 01/2021 - 04/2009
5	Retinoblastoma (Glioblastoma, Retinal) 06/2022 - 01/2018
3	Retinal Neovascularization 10/2017 - 04/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 01/2016
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2019 - 10/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2010 - 10/2009
1	Chromosomal Instability (Chromosome Stability) 06/2022
1	Neuroinflammatory Diseases 01/2021
1	Choroidal Neovascularization 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Glaucoma 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Inflammation (Inflammations) 10/2017
1	Idiopathic Pulmonary Fibrosis 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Lymphocytosis 01/2016
1	Hyperglycemia 01/2016
1	Retinal Degeneration 10/2014
1	Infections 03/2014
1	Optic Nerve Diseases (Optic Neuropathy) 04/2011
1	Ischemia 04/2010
1	Stroke (Strokes) 04/2010
1	Fibrosarcoma 08/2006
1	Tuberous Sclerosis (Bourneville's Disease) 02/2005

Drug/Important Bio-Agent (IBA)

6	Vascular Endothelial Growth Factor BIBA 01/2023 - 04/2009
6	platelet-derived growth factor C (PDGF-C)IBA 01/2018 - 04/2010
4	ChromatinIBA 06/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 07/2010
3	Small Interfering RNA (siRNA)IBA 01/2021 - 07/2010
2	UbiquitinIBA 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2004
2	Retinaldehyde (Retinal)IBA 01/2016 - 10/2014
2	Neuraminidase (Sialidase)IBA 01/2016 - 03/2014
2	histidine-rich proteinsIBA 02/2006 - 01/2004
1	Co-Repressor ProteinsIBA 06/2022
1	Histone MethyltransferasesIBA 12/2021
1	complement C3a receptorIBA 01/2021
1	SB 290157IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	AntioxidantsIBA 01/2019
1	DNA Ligase ATPIBA 01/2018
1	CamptothecinIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	caveolin-1 (82-101)IBA 10/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2017
1	pegaptanib (Macugen)FDA Link 01/2016
1	CollagenIBA 01/2016
1	Oxygen (Dioxygen)IBA 10/2014
1	Indicators and Reagents (Reagents)IBA 04/2011
1	Neutralizing AntibodiesIBA 07/2010
1	Retinal Pigments (Pigments, Visual)IBA 07/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2010
1	Becaplermin (PDGF-BB)FDA Link 07/2010
1	Platelet-Derived Growth FactorIBA 05/2010
1	Glycogen Synthase (Synthase I)IBA 05/2010
1	NeurotoxinsIBA 04/2010
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2009
1	CystatinsIBA 01/2009
1	histidylprolineIBA 08/2006
1	Histidine (L-Histidine)FDA Link 08/2006
1	Proline (L-Proline)FDA Link 08/2006
1	Heparin (Liquaemin)FDA LinkGeneric 02/2006
1	Blood Proteins (Serum Proteins)IBA 02/2006
1	Tuberous Sclerosis Complex 2 ProteinIBA 02/2005
1	Tuberous Sclerosis Complex 1 ProteinIBA 02/2005
1	Angiogenesis InhibitorsIBA 01/2004

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 06/2022 - 01/2018
2	Therapeutics 01/2016 - 07/2010
1	Axotomy 04/2010